Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Leila Asfour, Ahmed Kazmi & Rodney Sinclair. (2023) An evaluation of the available pharmacotherapy for the treatment of hirsutism. Expert Opinion on Pharmacotherapy 24:7, pages 803-813.
Read now
Read now
Zahra Bashiri, Nadia Sheibak, Fatemehsadat Amjadi & Zahra Zandieh. (2022) The role of myo-inositol supplement in assisted reproductive techniques. Human Fertility 0:0, pages 1-17.
Read now
Read now
Mariano Bizzarri, Patrizia Logoteta, Giovanni Monastra & Antonio Simone Laganà. (2022) An innovative approach to polycystic ovary syndrome. Journal of Obstetrics and Gynaecology 42:4, pages 546-556.
Read now
Read now
Oliver C. Watkins, Hannah E. J. Yong, Neha Sharma & Shiao-Yng Chan. (2022) A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy. Critical Reviews in Food Science and Nutrition 62:6, pages 1626-1673.
Read now
Read now
Samantha Celeste Garcia-Hernandez, Leonardo M. Porchia, Blanca T. Pacheco-Soto, Esther López-Bayghen & M. Elba Gonzalez-Mejia. (2021) Metformin does not improve insulin sensitivity over hypocaloric diets in women with polycystic ovary syndrome: a systematic review of 12 studies. Gynecological Endocrinology 37:11, pages 968-976.
Read now
Read now
Fabio Facchinetti, Pietro Cavalli, Andrew J. Copp, Rosario D’Anna, Eleni Kandaraki, Nicholas D. E. Greene & Vittorio Unfer. (2020) An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs). Expert Opinion on Drug Metabolism & Toxicology 16:12, pages 1187-1198.
Read now
Read now
Fabio Facchinetti, Marialuisa Appetecchia, Cesare Aragona, Arturo Bevilacqua, Maria Salome Bezerra Espinola, Mariano Bizzarri, Rosario D’Anna, Didier Dewailly, Evanthia Diamanti-Kandarakis, Imelda Hernández Marín, Zdravko A. Kamenov, Eleni Kandaraki, Antonio Simone Laganà, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Francesco Orio, Ali Cenk Ozay, Olga Papalou, Lali Pkhaladze, Giusy Porcaro, Nikos Prapas, Christophe O. Soulage, Annarita Stringaro, Artur Wdowiak & Vittorio Unfer. (2020) Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. Expert Opinion on Drug Metabolism & Toxicology 16:3, pages 255-274.
Read now
Read now
Simone Garzon, Antonio Simone Laganà & Giovanni Monastra. (2019) Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors. Expert Opinion on Drug Metabolism & Toxicology 15:9, pages 697-703.
Read now
Read now
Antoaneta Gateva, Vittorio Unfer & Zdravko Kamenov. (2018) The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecological Endocrinology 34:7, pages 545-550.
Read now
Read now
Peipei Jin & Yongyong Xie. (2018) Treatment strategies for women with polycystic ovary syndrome. Gynecological Endocrinology 34:4, pages 272-277.
Read now
Read now
Giovanni Monastra, Vittorio Unfer, Abdel Halim Harrath & Mariano Bizzarri. (2017) Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Gynecological Endocrinology 33:1, pages 1-9.
Read now
Read now
Mariano Bizzarri, Andrea Fuso, Simona Dinicola, Alessandra Cucina & Arturo Bevilacqua. (2016) Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1181-1196.
Read now
Read now
Articles from other publishers (50)
G. E. Chernukha & V. A. Pronina. (2023) Metabolic dysfunction correction as a method of restoring the function of the reproductive system in women. Meditsinskiy sovet = Medical Council:5, pages 90-97.
Crossref
Crossref
Mariano Bizzarri, Noemi Monti, Aurora Piombarolo, Antonio Angeloni & Roberto Verna. (2023) Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review. Nutrients 15:8, pages 1875.
Crossref
Crossref
Valeria Fedeli, Angela Catizone, Alessandro Querqui, Vittorio Unfer & Mariano Bizzarri. (2023) The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results. International Journal of Molecular Sciences 24:7, pages 6296.
Crossref
Crossref
Ali Cenk Özay, Scott Roseff & Shiao-yng Chan. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
87
110
.
Zdravko Kamenov & Mario Montanino Oliva. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
65
72
.
Giovanni Monastra, Simona Dinicola & Vittorio Unfer. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
9
29
.
Arturo Bevilacqua, Simona Dinicola & Mariano Bizzarri. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
53
64
.
Antonio Simone Laganà, Cesare Aragona & Nikos Prapas. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
175
195
.
Lali Pkhaladze, Vittorio Unfer & Didier Dewailly. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
151
165
.
Simon Alesi, Carolyn Ee, Lisa J Moran, Vibhuti Rao & Aya Mousa. (2022) Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome. Advances in Nutrition 13:4, pages 1243-1266.
Crossref
Crossref
V. Soldat-Stanković, S. Popović-Pejičić, S. Stanković, A. Prtina, G. Malešević, J. Bjekić-Macut, S. Livadas, S. Ognjanović, G. Mastorakos, D. Micić & D. Macut. (2021) The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. Journal of Endocrinological Investigation 45:3, pages 583-595.
Crossref
Crossref
Mehrukh Zehravi, Mudasir MaqboolIrfat Ara. (2022) Healthy Lifestyle and Dietary Approaches to Treating Polycystic Ovary Syndrome: A Review. Open Health 3:1, pages 60-65.
Crossref
Crossref
Tania S. Burgert & Emily Paprocki. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
193
204
.
Giuseppe Gullo, Andrea Etrusco, Gaspare Cucinella, Antonino Perino, Vito Chiantera, Antonio Simone Laganà, Rossella Tomaiuolo, Amerigo Vitagliano, Pierluigi Giampaolino, Marco Noventa, Alessandra Andrisani & Giovanni Buzzaccarini. (2021) Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview. International Journal of Molecular Sciences 22:21, pages 11825.
Crossref
Crossref
Simona Dinicola, Vittorio Unfer, Fabio Facchinetti, Christophe O. Soulage, Nicholas D. Greene, Mariano Bizzarri, Antonio Simone Laganà, Shiao-Yng Chan, Arturo Bevilacqua, Lali Pkhaladze, Salvatore Benvenga, Annarita Stringaro, Daniele Barbaro, Marialuisa Appetecchia, Cesare Aragona, Maria Salomè Bezerra Espinola, Tonino Cantelmi, Pietro Cavalli, Tony T. Chiu, Andrew J. Copp, Rosario D’Anna, Didier Dewailly, Cherubino Di Lorenzo, Evanthia Diamanti-Kandarakis, Imelda Hernández Marín, Moshe Hod, Zdravko Kamenov, Eleni Kandaraki, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Maurizio Nordio, Ali C. Ozay, Olga Papalou, Giuseppina Porcaro, Nikos Prapas, Scott Roseff, Monica Vazquez-Levin, Ivana Vucenik & Artur Wdowiak. (2021) Inositols: From Established Knowledge to Novel Approaches. International Journal of Molecular Sciences 22:19, pages 10575.
Crossref
Crossref
Maria Letizia Petroni, Lucia Brodosi, Francesca Marchignoli, Anna Simona Sasdelli, Paolo Caraceni, Giulio Marchesini & Federico Ravaioli. (2021) Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges. Nutrients 13:8, pages 2748.
Crossref
Crossref
Waleed Hassan Almalki. (2021) A review on inositol’s potential in cyclic disturbances of adipose-endocrinology-associated polycystic ovary syndrome. Molecular and Cellular Biochemistry 476:8, pages 2943-2949.
Crossref
Crossref
Anupama Bahadur, Hitanshi Arora, Anoosha K Ravi, Manisha Naithani, Yogesh Bahurupi, Jaya Chaturvedi, Megha Ajmani & Rajlaxmi Mundhra. (2021) Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial. Cureus.
Crossref
Crossref
Ol'ga S. Alyautdina, Viktoriya Y. Prilutskaya & Ekaterina I. Krylova. (2021) The use of inositol stereoisomers for the treatment of patients with clinical and biochemical signs of hyperandrogenism. V.F.Snegirev Archives of Obstetrics and Gynecology 8:2.
Crossref
Crossref
Giovanni Monastra, Ivana Vucenik, Abdel Halim Harrath, Saleh H. Alwasel, Zdravko A. Kamenov, Antonio Simone Laganà, Noemi Monti, Valeria Fedeli & Mariano Bizzarri. (2021) PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol. Frontiers in Endocrinology 12.
Crossref
Crossref
Showkat Rashid, Bilal A. Bhat & Goverdhan Mehta. (2020) Conceptualization and Synthesis of the First Inosito‐Inositol (Decahydroxydecalin, DHD): In silico Binding to β‐Amyloid Protein. Chemistry – A European Journal 26:71, pages 17005-17010.
Crossref
Crossref
Andrea Cignarella, Roberto Mioni, Chiara Sabbadin, Francesca Dassie, Matteo Parolin, Roberto Vettor, Mattia Barbot & Carla Scaroni. (2020) Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS. International Journal of Molecular Sciences 21:24, pages 9554.
Crossref
Crossref
Eser Colak, Emel Ebru Ozcimen, Yusuf Aytac Tohma & Mehmet Ufuk Ceran. (2020)
May myo‐inositol and
d
‐chiro‐inositol (40:1) treatment be a good option on normal‐weighted polycystic ovary syndrome patients without insulin resistance?
. Journal of Obstetrics and Gynaecology Research 46:12, pages 2605-2611.
Crossref
Crossref
Vittorio Unfer, Simona Dinicola, Antonio Simone Laganà & Mariano Bizzarri. (2020) Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS. International Journal of Molecular Sciences 21:19, pages 7157.
Crossref
Crossref
Antonio Aversa, Sandro La Vignera, Rocco Rago, Alessandra Gambineri, Rossella E. Nappi, Aldo E. Calogero & Alberto Ferlin. (2020) Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions. Frontiers in Endocrinology 11.
Crossref
Crossref
Fabio Facchinetti, Maria Salome Bezerra Espinola, Didier Dewailly, Ali Cenk Ozay, Nikos Prapas, Mónica Vazquez-Levin, Artur Wdowiak, Vittorio Unfer, Fabio Facchinetti, Vittorio Unfer, Marialuisa Appetecchia, Cesare Aragona, Matteo Bertelli, Arturo Bevilacqua, Maria Salome Bezerra Espinola, Mariano Bizzarri, Pietro Cavalli, Andrew Copp, Rosario D’Anna, Didier Dewailly, Nicholas Greene, Imelda Hernández Marín, Zdravko A. Kamenov, Eleni Kandaraki, Evanthia Diamanti-Kandarakis, Antonio Simone Laganà, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Ali Cenk Ozay, Olga Papalou, Lali Pkhaladze, Giusy Porcaro, Nikos Prapas, Christophe O. Soulage, Annarita Stringaro, Mónica Vazquez-Levin & Artur Wdowiak. (2020) Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART). Trends in Endocrinology & Metabolism 31:8, pages 570-579.
Crossref
Crossref
Fabio Facchinetti, Vittorio Unfer, Didier Dewailly, Zdravko A. Kamenov, Evanthia Diamanti-Kandarakis, Antonio Simone Laganà, John E. Nestler & Christophe O. Soulage. (2020) Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends in Endocrinology & Metabolism 31:6, pages 435-447.
Crossref
Crossref
M. Caputo, E. Bona, I. Leone, M.T. Samà, A. Nuzzo, A. Ferrero, G. Aimaretti, P. Marzullo & F. Prodam. (2020) Inositols and metabolic disorders: From farm to bedside. Journal of Traditional and Complementary Medicine 10:3, pages 252-259.
Crossref
Crossref
Małgorzata Szczuko, Viktoria Hawryłkowicz, Justyna Kikut & Arleta Drozd. (2020) The implications of vitamin content in the plasma in reference to the parameters of carbohydrate metabolism and hormone and lipid profiles in PCOS. The Journal of Steroid Biochemistry and Molecular Biology 198, pages 105570.
Crossref
Crossref
Heidy Cabrera-Cruz, Lorena Oróstica, Francisca Plaza-Parrochia, Ignacio Torres-Pinto, Carmen Romero & Margarita Vega. (2020) The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment. American Journal of Physiology-Endocrinology and Metabolism 318:2, pages E237-E248.
Crossref
Crossref
Kai-Lun Hu, Fen-Ting Liu, Huiyu Xu, Rong Li & Jie Qiao. (2020) High antimüllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome. Fertility and Sterility 113:2, pages 444-452.e1.
Crossref
Crossref
Daniela Romualdi, Valeria Versace & Antonio Lanzone. (2020) What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment. Therapeutic Advances in Reproductive Health 14, pages 263349412090870.
Crossref
Crossref
Wenwen Lei, Yang Gao, Shiruo Hu, Dongying Liu & Qiu Chen. (2020) Effects of inositol and alpha lipoic acid combination for polycystic ovary syndrome. Medicine 99:30, pages e20696.
Crossref
Crossref
Anna Wojciechowska, Adam Osowski, Marcin Jóźwik, Ryszard Górecki, Andrzej Rynkiewicz & Joanna Wojtkiewicz. (2019) Inositols’ Importance in the Improvement of the Endocrine–Metabolic Profile in PCOS. International Journal of Molecular Sciences 20:22, pages 5787.
Crossref
Crossref
Т. Л. Архипкина & Л. П. Любимова. (2019) Efficiency of the D-chiro-inositol for the polycystic ovary syndrome. Reproductive Endocrinology 0:45, pages 57-62.
Crossref
Crossref
Marian G Showell, Rebecca Mackenzie-Proctor, Vanessa Jordan, Ruth Hodgson & Cindy Farquhar. (2018) Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Crossref
Mario Montanino Oliva, Giovanna Buonomo, Marco Calcagno & Vittorio Unfer. (2018) Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. Journal of Ovarian Research 11:1.
Crossref
Crossref
Antonio Simone Laganà, Simone Garzon, Jvan Casarin, Massimo Franchi & Fabio Ghezzi. (2018) Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach. Trends in Endocrinology & Metabolism 29:11, pages 768-780.
Crossref
Crossref
Pedro-Antonio Regidor, Adolf Eduard Schindler, Bernd Lesoine & Rene Druckman. (2018) Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Hormone Molecular Biology and Clinical Investigation 34:2.
Crossref
Crossref
Antonio Malvasi, Andrea Tinelli, Domenico Baldini, Rossana G. Iannitti & Bernard Fioretti. (2018) Nutraceutical prospective: The synergetic mechanism of action of inositols and resveratrol on metabolic syndrome. The EuroBiotech Journal 2:1, pages 35-38.
Crossref
Crossref
John E. Nestler & Antonio Simone Laganà. 2018. Infertility in Women with Polycystic Ovary Syndrome. Infertility in Women with Polycystic Ovary Syndrome
213
226
.
R Hanna, T Wehbe & EA Jaoude. (2017) Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome. International Journal of Clinical Endocrinology and Metabolism 3:1, pages 029-033.
Crossref
Crossref
Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos Prapas & Fabio Facchinetti. (2017) Inositol(s) from Bench to Bedside in Endocrinology and Gynecology. International Journal of Endocrinology 2017, pages 1-2.
Crossref
Crossref
Arturo Bevilacqua & Mariano Bizzarri. (2016) Physiological role and clinical utility of inositols in polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology 37, pages 129-139.
Crossref
Crossref
Marian G Showell, Rebecca Mackenzie-Proctor, Vanessa Jordan, Ruth Hodgson, Julie Brown & Cindy Farquhar. (2016) Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ricardo Azziz, Enrico Carmina, ZiJiang Chen, Andrea Dunaif, Joop S. E. Laven, Richard S. Legro, Daria Lizneva, Barbara Natterson-Horowtiz, Helena J. Teede & Bulent O. Yildiz. (2016) Polycystic ovary syndrome. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Sharon Stein Merkin, Jennifer L. Phy, Cynthia K. Sites & Dongzi Yang. (2016) Environmental determinants of polycystic ovary syndrome. Fertility and Sterility 106:1, pages 16-24.
Crossref
Crossref
Mariano Bizzarri, Simona Dinicola, Arturo Bevilacqua & Alessandra Cucina. (2016) Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate. International Journal of Endocrinology 2016, pages 1-14.
Crossref
Crossref
Bernd Lesoine & Pedro-Antonio Regidor. (2016) Prospective Randomized Study on the Influence of Myoinositol in PCOS Women Undergoing IVF in the Improvement of Oocyte Quality, Fertilization Rate, and Embryo Quality. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos Prapas & Fabio Facchinetti. (2016) Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. International Journal of Endocrinology 2016, pages 1-12.
Crossref
Crossref